Mapping Menstrual Health Research in France: A Scoping Review of Peer-Reviewed Literature Up to 2024
Violeta Alarcão,1,2 Elise de La Rochebrochard3,4 1Centre for Research and Studies in Sociology, Iscte— University Institute of Lisbon, Lisbon, Portugal; 2Institute of Environmental Health, Faculty of Medicine, University of Lisbon, Lisbon, Portugal ...
Alarcão V, de La Rochebrochard E
doaj
'The law is very, very outdated and not keeping up with the technology': novel forms of assisted gestation, legal challenges, and perspectives of reproductive rights advocates in England and Wales. [PDF]
Romanis EC.
europepmc +1 more source
ADOLESCENT SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS IN EL SALVADOR
Rafael Cortez
openalex +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
Debilitated Lifeworlds: Women's Narratives of Forced Sterilization as Delinking from Reproductive Rights. [PDF]
Chaparro-Buitrago J.
europepmc +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Knowledge and involvement of husbands in the reproductive rights of women in Harar, eastern Ethiopia. [PDF]
Mohammed A +6 more
europepmc +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Women’s Reproductive Health and Rights Through the Lens of the COVID-19 Pandemic
Mona Larki +2 more
openalex +2 more sources

